Digestive System Neuroendocrine Tumor G2

Digestive System Neuroendocrine Tumor G2 — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05773274	Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial	recruiting	Phase 2	100	National Cancer Institute (NCI)NIH	2	Sep 24, 2026	clinicaltrials
NCT06016855	Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors	recruiting	Phase 4	6	Vanderbilt-Ingram Cancer CenterOTHER	1	Jun 24, 2026	clinicaltrials
NCT07150546	Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.	recruiting	Phase 1	15	Emory UniversityOTHER	1	Mar 2, 2026	clinicaltrials
NCT06080204

Data updated 4 days agoSource updated Sep 24, 2026source: clinicaltrials